Skip to main content

Table 2 Alterations of the number of patients with nausea and vomiting in acute and delayed phases

From: Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience

 

Nausea (n = 127)

Vomiting (n = 127)

Acute (0–24 h)

Delayed (24–120 h)

Acute (0–24 h)

Delayed (24–120 h)

Baseline

33 (26%)

127 (100%)

2 (2%)

21 (17%)

Post-treatment

11 (9%)

83 (65%)

1 (1%)

6 (5%)